Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lofexidine 200microgram tablets
0410030D0AAAAAA
|
Lofexidine hydrochloride | Lofexidine hydrochloride | Central Nervous System | No data available |
|
Lomont 70mg/5ml oral suspension
0403010R0BCAAAL
|
Lomont | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lorazepam 1.125mg/5ml oral liquid
0401020P0AACACA
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2.5mg orodispersible tablets
0401020P0AACLCL
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2mg/1ml solution for injection ampoules
0401020P0AACHCH
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2mg/1ml solution for injection vials
0401020P0AACJCJ
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 2mg/5ml oral liquid
0401020P0AABRBR
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 3.75mg/5ml oral liquid
0401020P0AABZBZ
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 400micrograms/5ml oral liquid
0401020P0AABSBS
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lorazepam 4mg/5ml oral liquid
0401020P0AABXBX
|
Lorazepam | Lorazepam | Central Nervous System | No data available |
|
Lormetazepam 125micrograms/5ml oral suspension
0401010P0AAAHAH
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
|
Lormetazepam 1mg/5ml oral suspension
0401010P0AAAGAG
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
|
Lormetazepam 2mg/5ml oral suspension
0401010P0AAAEAE
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
|
Lormetazepam 500micrograms/5ml oral suspension
0401010P0AAAFAF
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
|
Lotprosin XL 24mg capsules
0411000F0BGACAG
|
Lotprosin XL | Galantamine | Central Nervous System | No data available |
|
Loxapac 10mg capsules
0402010M0BBAAAA
|
Loxapac | Loxapine succinate | Central Nervous System | No data available |
|
Loxapac 25mg capsules
0402010M0BBABAB
|
Loxapac | Loxapine succinate | Central Nervous System | No data available |
|
Loxapac 50mg capsules
0402010M0BBACAC
|
Loxapac | Loxapine succinate | Central Nervous System | No data available |
|
Loxapine 10mg capsules
0402010M0AAAAAA
|
Loxapine succinate | Loxapine succinate | Central Nervous System | No data available |
|
Loxapine 25mg capsules
0402010M0AAABAB
|
Loxapine succinate | Loxapine succinate | Central Nervous System | No data available |
|
Loxapine 50mg capsules
0402010M0AAACAC
|
Loxapine succinate | Loxapine succinate | Central Nervous System | No data available |
|
Ludiomil 10mg tablets
0403010S0BBAAAA
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Ludiomil 25mg tablets
0403010S0BBABAB
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Ludiomil 50mg tablets
0403010S0BBACAE
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
|
Ludiomil 75mg tablets
0403010S0BBADAD
|
Ludiomil | Maprotiline hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.